Hosted virtual Analyst Day showcasing lead program KRRO-121’s potential to be a first-in-class transformational treatment for hyperammonemia in patients with urea cycle disorders (UCDs) and hepatic ...

Happy birthday, David Attenborough! Born May 8, 1926, nature’s greatest hype man has now lived a full century and counting. No small feat, especially since ONS data shows that men make up only 20% of ...

Part A of LIGHTHOUSE Trial reinforce ATSN-201's favorable safety profile and durable structural and functional benefits in ...

Drug Farm today announced ophthalmologic and central nervous system (CNS) findings from its Phase 1b study of DF-003, a first ...

Abstract: The problems and the guarantee of safety are very important, as they can influence clinical results noticeably if a timely and accurate determination of fetal health is made. Typical ...

A new twin study suggests your genes may play a bigger role in your future success than your upbringing. Researchers found ...

Meet Cody Robb, an IVF baby who became an embryologist to help others build families. Read his inspiring story and learn about IVF advancements.

Positive 12-month data from the OCU410 Phase 2 ArMaDa clinical trial for geographic atrophy (GA) indicates a statistically ...

Over the past three decades, meaningful progress has been made in the research and understanding of cystic fibrosis (CF). 1 ...

Ascidian Therapeutics, a biotechnology company seeking to treat human diseases by rewriting RNA, announced the completion of the adult dose escalation portion of the STELLAR phase 1/2 clinical trial ...

Ascidian Completes Dose Escalation Portion Of Phase 1/2 STELLAR Trial Of ACDN-01 For Stargardt Disease And Announces Expanded Clinical Study Plans. STELLAR to begin enrolling pediatric subjects STARPA ...